Typbar Typhoid Conjugate Vaccine (TVC)

  • It is a Typhoid Vaccine developed by Hyderabad based Bharat Biotech
  • WHO has given its approval for global use of this vaccine.
  • Typbar TCV is world’s first typhoid vaccine clinically proven to be administered to children from six months of age to adults, and confers long-term protection against typhoid fever.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top